| Source: |
| Type: |
| Blood-Brain Barrier(BBB) is a term often used regarding if a product has the ability to cross the BBB. |
| Glioblastoma is a fast-growing and aggressive brain tumor. |
| 2731- | BetA, | Betulinic Acid for Glioblastoma Treatment: Reality, Challenges and Perspectives |
| - | Review, | GBM, | NA | - | Review, | Park, | NA | - | Review, | AD, | NA |
| - | vitro+vivo, | GBM, | U251 |
| 6024- | CGA, | Phase I study of chlorogenic acid injection for recurrent high-grade glioma with long-term follow-up |
| - | Trial, | GBM, | NA |
| 4489- | Chit, | SeNPs, | Inhibiting Metastasis and Improving Chemosensitivity via Chitosan-Coated Selenium Nanoparticles for Brain Cancer Therapy |
| - | in-vitro, | GBM, | U87MG |
| 2511- | H2, | Molecular hydrogen suppresses glioblastoma growth via inducing the glioma stem-like cell differentiation |
| - | in-vivo, | GBM, | U87MG |
| 4778- | Lyco, | Lycopene exerts cytotoxic effects by mitochondrial reactive oxygen species–induced apoptosis in glioblastoma multiforme |
| - | in-vitro, | GBM, | GBM8401 |
| 3339- | QC, | Quercetin suppresses ROS production and migration by specifically targeting Rac1 activation in gliomas |
| - | in-vitro, | GBM, | C6 | - | in-vitro, | GBM, | IMR32 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:27 Cells:% prod#:% Target#:1123 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid